4//SEC Filing
Brady Todd R. 4
Accession 0001437749-24-018619
CIK 0001855175other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 5:54 PM ET
Size
5.3 KB
Accession
0001437749-24-018619
Insider Transaction Report
Form 4
Brady Todd R.
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-24+29,500→ 29,500 totalExercise: $15.76Exp: 2034-05-23→ Class A Common Stock (29,500 underlying)
Footnotes (1)
- [F1]Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Program, as amended. One-third of the option shares vest on April 5, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.
Documents
Issuer
Contineum Therapeutics, Inc.
CIK 0001855175
Entity typeother
Related Parties
1- filerCIK 0001767644
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 5:54 PM ET
- Size
- 5.3 KB